Literature DB >> 20942663

Regulatory action on rosiglitazone by the U.S. Food and Drug Administration.

Janet Woodcock1, Joshua M Sharfstein, Margaret Hamburg.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20942663     DOI： 10.1056/NEJMp1010788

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  42 in total

1.  CGRRF1 as a novel biomarker of tissue response to metformin in the context of obesity.

Authors:  Qian Zhang; Rosemarie Schmandt; Joseph Celestino; Adrienne McCampbell; Melinda S Yates; Diana L Urbauer; Russell R Broaddus; David S Loose; Gregory L Shipley; Karen H Lu
Journal:  Gynecol Oncol       Date:  2014-04       Impact factor: 5.482

2.  Changing Patterns of Glucose-Lowering Medication Use in VA Nursing Home Residents With Diabetes, 2005 to 2011.

Authors:  Sei J Lee; Irena Stijacic-Cenzer; Caroline Barnhart; Keelan McClymont; Michael A Steinman
Journal:  J Am Med Dir Assoc       Date:  2015-08-10       Impact factor: 4.669

Review 3.  [Diabetic kidney disease - Update 2016].

Authors:  Harald Sourij; Roland Edlinger; Friedrich Prischl; Martin Auinger; Alexandra Kautzky-Willer; Marcus D Säemann; Rudolf Prager; Martin Clodi; Guntram Schernthaner; Gert Mayer; Rainer Oberbauer; Alexander R Rosenkranz
Journal:  Wien Klin Wochenschr       Date:  2016-04       Impact factor: 1.704

4.  National Trends in Treatment Initiation for Nursing Home Residents With Diabetes Mellitus, 2008 to 2010.

Authors:  Andrew R Zullo; David D Dore; Lori Daiello; Rosa R Baier; Roee Gutman; David R Gifford; Robert J Smith
Journal:  J Am Med Dir Assoc       Date:  2016-03-24       Impact factor: 4.669

5.  Rosiglitazone: trials, tribulations and termination.

Authors:  Andrew J Krentz
Journal:  Drugs       Date:  2011-01-22       Impact factor: 9.546

6.  How Did Multiple FDA Actions Affect the Utilization and Reimbursed Costs of Thiazolidinediones in US Medicaid?

Authors:  Jason C Hsu; Dennis Ross-Degnan; Anita K Wagner; Fang Zhang; Christine Y Lu
Journal:  Clin Ther       Date:  2015-05-11       Impact factor: 3.393

Review 7.  Nuclear receptors and epigenetic regulation: opportunities for nutritional targeting and disease prevention.

Authors:  Donato F Romagnolo; Janos Zempleni; Ornella I Selmin
Journal:  Adv Nutr       Date:  2014-07-14       Impact factor: 8.701

8.  Patterns of medication initiation in newly diagnosed diabetes mellitus: quality and cost implications.

Authors:  Nihar R Desai; William H Shrank; Michael A Fischer; Jerry Avorn; Joshua N Liberman; Sebastian Schneeweiss; Juliana Pakes; Troyen A Brennan; Niteesh K Choudhry
Journal:  Am J Med       Date:  2012-03       Impact factor: 4.965

9.  Drugs and trials: lessons from Plato.

Authors:  Howard Trachtman
Journal:  Clin Ther       Date:  2013-04-13       Impact factor: 3.393

10.  New considerations in the design of clinical trials for the treatment of acute leukemia.

Authors:  Christopher S Hourigan; Judith E Karp
Journal:  Clin Investig (Lond)       Date:  2011-04-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.